HealthTell is committed to empowering the next generation of diagnostics and therapeutics for complex immune-mediated diseases such as cancer, autoimmune disorders, and infectious disease.
Location: United States, California, San Ramon
Employees: 51-200
Total raised: $30M
Founded date: 2012
Investors 2
| Date | Name | Website |
| - | Third Poin... | thirdpoint... |
| - | BlueTree V... | bluetreeve... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 14.03.2016 | Series B | $26M | - |
| 23.08.2013 | - | $4M | - |
Mentions in press and media 8
| Date | Title | Description |
| 14.03.2016 | HealthTell Completes $26M Series B Financing | HealthTell, Inc., a San Ramon, CA-based a developer of a diagnostic platform capable of assessing an individual’s immune system response to specific diseases, raised $26m in Series B funding. The round was led by Third Point Ventures. In co... |
| 09.03.2016 | Theranos competitor HealthTell raises $26M for single-drop-of-blood diagnostics that profile immune response | Prior investors in the company include Vital Venture Capital, Paladin Capital Group, Acadia Woods Partners, Cambridge Global Capital and the Broe Group. MedCity News is waiting to hear back from HealthTell to learn about how it’ll use this ... |
| 11.05.2015 | HealthTell’s marketing language jabs at Theranos (also, it’s raising $5M for its own single-drop-of-blood diagnostics) | HealthTell’s language is pretty amusing: “HealthTell takes pride in being a transparent, data driven company passionate about sharing our diagnostic technology with the world.” Generally the opposite approach of Theranos, no? It’s also curi... |
| 23.08.2013 | HealthTell Raises $4M in Funding | HealthTell, Inc., a Chandler, AZ-based biotech spinout from Arizona State University, raised $4m in funding. The company intends to use the funds to develop and commercialize a new test for lung, breast, prostate and colorectal cancer. Led ... |
| 21.08.2013 | ASU spinout lands $4M for early-stage cancer detection diagnostic, piques US military interest | The startup has gotten the attention of the US military, too: HealthTell is also supplying chips for two ASU projects funded by the U.S. Department of Defense and its Defense Threat Reduction Agency (DTRA). DTRA is interested in using the d... |
| - | ASU spinout lands $4M for early-stage cancer detection diagnostic, piques US military interest | HealthTell Inc., an Arizona State University spinout, has raised $4 million to commercialize a test for lung, breast, prostate and colorectal cancer. The Chandler, Ariz.-based startup is working to develop a variety of health monitoring too... |
| - | HealthTell’s marketing language jabs at Theranos (also, it’s raising $5M for its own single-drop-of-blood diagnostics) | Examining the immune system’s response to disease has been a hot new area in diagnostics – particularly when done with a single drop of blood, as has been widely publicized with the ever-evasive Theranos. Arizona startup HealthTell studies ... |
| - | Theranos competitor HealthTell raises $26M for single-drop-of-blood diagnostics that profile immune response | Single-drop-of-blood diagnostics startups are still able to attract a pretty penny, despite the fallout from fallen unicorn Theranos. Arizona upstart HealthTell is in the midst of an impressive $35.5 million funding round, according to a re... |